Next Article in Journal
Evolution of Early Postoperative Cardiac Rehabilitation in Patients with Acute Type A Aortic Dissection
Next Article in Special Issue
An Ultra-Short Measure of Excessive Daytime Sleepiness Is Related to Circadian Biological Rhythms: The French Psychometric Validation of the Barcelona Sleepiness Index
Previous Article in Journal
Surgical Outcomes and Trends for Chronic Pancreatitis: An Observational Cohort Study from a High-Volume Centre
Previous Article in Special Issue
Chronotype Profile, Stress, Depression Level, and Temporomandibular Symptoms in Students with Type D Personality
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 11
Issue 8
10.3390/jcm11082106
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessment of Insomnia Symptoms, Quality of Life, Daytime Sleepiness, and Psychoactive Substance Use among Polish Students: A Cross-Sectional Online Survey for Years 2016–2021 before and during COVID-19 Pandemic

by
Mateusz Babicki
1,
Patryk Piotrowski
2,3,* and
Agnieszka Mastalerz-Migas
1
1
Department of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland
2
Section of Epidemiology and Social Psychiatry, Department and Clinic of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland
3
Division of Consultation Psychiatry and Neuroscience, Wroclaw Medical University, 50-367 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(8), 2106; https://doi.org/10.3390/jcm11082106
Submission received: 30 January 2022 / Revised: 29 March 2022 / Accepted: 7 April 2022 / Published: 9 April 2022
(This article belongs to the Special Issue Sleep and Circadian Rhythms in Psychiatric Disorders)
Versions Notes

Abstract

:
Sleep disorders are a serious health problem worldwide, and insomnia is their most common manifestation. An increasing number of people have insomnia every year, young adults, especially. Due to the importance that sleep has in almost every aspect of our lives, the need to monitor disturbances in circadian rhythms has arisen. Therefore, this study aimed to assess the prevalence of sleep disorders among Polish students, including their quality of life (QOL) and drug use patterns. The study also investigated associations between sleep, QoL, and drug use. The study was conducted in 2016–2021 based on the self-made sociodemographic questionnaire, as well as standardized psychometric tools: Athens Insomnia Scale (AIS), Epworth Sleepiness Scale (ESS), and Manchester Short Assessment of quality of life (MANSA). A total of 14,844 students participated in the study. The majority were women (80.7%), of which 3425 (23.1%) were medical students, with the most numerous representing medical and dental faculties, 1884 (57.2%). Before the COVID-19 pandemic, 52.1% of the surveys were collected; 54.1% of respondents had insomnia as indicated by the AIS scores, and 26.1% displayed sleepiness during the day. Female students, the first-year college students, more often suffered from sleep disorders. Drug use was widespread among Polish students, correlating with sleep assessment results and QoL. In conclusion, sleep disorders are a significant clinical problem among Polish students. Female and junior students’ years are more prone to sleep deprivation. Insufficient sleep can be associated with a lower QoL score and psychoactive substance use. The effects of the COVID-19 pandemic on sleep are not conclusive, because there was decreasing quality for longer sleep durations. In order to analyze these associations, there is a need for further in-depth study.

1. Introduction

Sleep disorders are a significant health problem worldwide, and insomnia is the most common disease that affects increasingly more people every year [1,2]. Young adults, often students, are more prone to sleep deprivation [3]. Several reports have estimated that even 40–60% of young adults have sleep deficits [4,5,6,7,8]. Biological and social factors and incorrect behavior patterns are primary reasons for such phenomena. Because of their age, the functioning of most students can follow symptoms of the so-called “youthful” delayed sleep-wake phase disorder. Namely, their evening and night periods become preferential to increased activity, while the day, especially in the morning, is a period of sleep and rest. Getting up early, necessary to fulfill new adult social roles, is very difficult, and the amount of sleep becomes insufficient [9]. Undoubtedly, the changes in social life functioning have a significant impact. A period of education at the university level is associated with many new life experiences such as changing the place of residence, increased independence, changing peer groups, and new duties related to educational learning [10]. In addition, the population of students rarely follows proper sleep hygiene and frequently overuse psychoactive substances affecting sleep physiology [11,12,13].
Sleep is fundamental to life functions. Healthy sleep is necessary to maintain mental and physical well-being and proper emotional and social functioning, while its disturbances may have many adverse outcomes [14,15]. First, sleep deficit may lead to excessive daytime sleepiness [10]. Second, individuals suffering from sleep disorders exhibit problems with attention, memory, and concentration, which result in poor performance in study and work [16,17,18,19]. The university student population is also predisposed to chronic diseases such as diabetes, hypertension, obesity, or myocardial infarction with an increased risk of death [20,21]. These people have a lowered quality of life (QoL) and an increased risk of developing psychiatric diseases, and a tendency to risk behaviors and poor social relations [22]. Because sleep deterioration enormously affects mental health, physical health, and everyday functioning, there is a need of close monitoring of the COVID-19 pandemic deteriorating almost every aspect of human life, as shown by recent studies [22]. Moreover, the very recent studies have indicated that the adverse psychological outcomes of the COVID-19 pandemic such as anxiety, depression, sleep disorders, and post-traumatic stress disorder more often affect younger adults, including university students [23]. There is also evidence of changes in the psychoactive drug use patterns in the COVID-19 pandemic, depending on the data collection period, sample population, and the initial level of drug use [24,25].
At the beginning of the 1970s, the definition of quality of life (QOL) was introduced to medicine. Since then, there has been growing interest in applying QoL into medical practice. According to the WHO definition, QoL is a subjective assessment of an individual’s life situation concerning the individual’s culture, value system, goals, expectations, and interests [26]. Therefore, measuring a patient’s QOL provides an essential possibility for assessing a patient’s perspective concerning an individual life situation. As shown, patients’ subjective feelings influence, to a large extent, their behavior. Several studies have shown that patients with decreased QoL due to a specific therapeutic therapy are more likely to give it up despite clinical effectiveness. Nonetheless, the nature of QOL measurement is challenging. Current research usually uses a questionnaire technique, covering many aspects of life and being interpreted by having a total score value. An exemplary survey measurement is the Manchester Short Assessment of quality of life (MANSA) [27,28,29].
To sum up, studies so far have shown that there is a close correlation between insomnia and daytime sleepiness, with people suffering from insomnia having a higher level of daytime sleepiness. Additionally, both of these parameters significantly lower the assessment of the quality of life of students. Moreover, it has been proven that both women, students of younger years and students of medical faculties show greater problems with sleep than others [2,6,10,14,15]. The negative impact of the ongoing COVID-19 pandemic on sleep quality and the assessment of quality of life has also been proven. During the ongoing pandemic, an increase in sleep problems was observed both in the general population and among students [22,23,24,25]. Moreover, the period of the pandemic also contributed to changes in the scope of stimulants used, with the impact varying depending on the period of data collection and the study group. Due to the connections between sleepiness, insomnia, quality of life, and the drugs used, and the impact of the COVID-19 pandemic on them, we decided to conduct a study that combines individual aspects [24,25].
This study aimed to assess disorders of circadian rhythms among Polish students, including their QoL and psychoactive drug use patterns. In addition, is there a relationship between insomnia, daytime sleepiness, and quality of life? Does the use of psychoactive substances affect the level of insomnia, daytime sleepiness, and the assessment of the quality of life, and is there a difference in their assessment in terms of gender, field of study, and year of study? Finally, has the COVID-19 pandemic contributed to the deterioration in the quality of sleep and life of Polish students? Based on previous reports [1,2,4,20,21,22,23,24,25], the authors formulated the following research hypotheses: (1) Sleep disorders are common among Polish students. (2) Sleep disorders would be higher among female university students. (3) There would be an association between sleep disturbance and QoL. (4) The COVID-19 pandemic would exacerbate sleep disorders and reduce QOL among students. (5) Male university students would be more prone to risk behaviors, including the use of psychoactive substances.

2. Materials and Methods

2.1. Methodology

The study used a survey questionnaire design using standardized questionnaires distributed online via the Facebook social network in groups associating students. The students’ status in most cases was confirmed via their membership. The survey was administered to students living and studying in Poland, and participation in the survey was anonymous and voluntary. The survey data collection covered the period from 31 January 2016 to 1 January 2021.
At each stage of the study, the respondents had the opportunity to terminate their participation without giving any reason. After being familiarized with objectives and the research methodology, the respondents were asked to give informed consent to participate in the study. Consented participants were then requested to continue the study procedure. The survey questionnaire consisted of two sections. The first one assessed socio-demographic status of the respondents, including age, sex, place of residence, field of study, and year of study. Then, the survey assessed frequencies of using psychoactive substances (alcohol, cannabinoids, psychostimulants) and hypnotics. The second part involved three standardized psychometric tools: Athens Insomnia Scale (AIS), Epworth Sleepiness Scale (ESS), and Manchester Short Assessment of quality of life (MANSA).

2.1.1. Athens Insomnia Scale (AIS)

The AIS scale is an 8-item tool for quantitative evaluation of insomnia symptoms based on the ICD-10 criteria. It uses a four-point Likert scale (0—no difficulty, 3—severe difficulty) assessing difficulty in falling asleep, waking up at night, waking up in the morning, total sleep time, sleep quality, well-being the next day, mental and physical fitness the next day, and sleepiness during the day, occurring at least 3 times in the last 14 days. The maximum score that can be earned is 24. The Polish adaptation of AIS was used in which the cut-off point for diagnosing insomnia was set at 8 scores. The measurement characterizes high sensitivity (93%) and specificity (85%). Moreover, a high reliability of the Cronbach’s alpha was shown, yielding a value of 0.832 [30,31,32].

2.1.2. Epworth Sleepiness Scale (ESS)

The ESS scale measures excessive sleepiness and is one of the most common in making the diagnosis of sleepiness. The ESS consists of 8 questions about the likelihood of falling asleep in 8 typical everyday situations (e.g., watching TV, sitting in a public place, lying down and relaxing in the afternoon, etc.). The maximum ESS score is 24. The following point criteria were adopted in the present study: 0–10 points means no daytime sleepiness, 11–14 points—sleepiness, and 15 points and above—pathological sleepiness, which requires consultation with a doctor. The reliability of the scale measured with Cronbach’s alpha coefficient was 0.755 [33,34,35].

2.1.3. Manchester Short Assessment (MANSA)

The MANSA measures the subjective assessment of several aspects of an individual’s life satisfaction. MANSA consists of 16 questions covering individual spheres of life. In 12 questions, the respondents give answers on a Likert scale from 1 (it could not be worse) to 7 (it could not be better). The remaining 4 items include affirmative (2 points) or negative (1 point) answers. The maximum MANSA score is 92, and the QoL interpretation involves the total scored obtained by respondent, where the higher the value, the better the assessed QoL. Some reports may also use individual questions to evaluate life satisfaction. Cronbach’s alpha was 0.810 [36,37].

2.2. Statistical Analysis

The analysis employed numerical and rank-based values. The chi-square test was used to assess significant differences in the demographics of the university student population before and during the pandemic and the frequency of drug use in both periods of time. The age differences between groups before and during the pandemic was tested using the t-test. Linear regression examined the effects of sociodemographic variables and stimulants on the AIS, ESS, and MANSA scores. The linear regression models included two predictors, including their interaction: the first predictor was “Pandemic” (with two levels: “Before” vs. “During” Pandemic). Separate models included gender (female vs. male), year of study (I–VI), major (medicine, engineering, humanities, economics, biology), type of faculty (medical studies), alcohol consumption (yes/no), consumption of cannabinoids (yes/no), psychostimulants (yes/no), and use of hypnotics (yes/no). The effects of the period of the study (“before” and “during” a pandemic) and demographics on MANSA life satisfaction were analyzed using the ordinate polynomial logistic regression. It included dependent variables such as the subsequent MANSA items with rank values and the predictors of the study period and demographic variables in separate models. The relationships between drug use and the pandemic and demographic variables were investigated similarly. The correlation between the scales was performed using Pearson’s correlation coefficient. The Statistica program (13.3.) was used to compute t-test and chi-square statistics and general linear models. The ordinate polynomial logistic regression models were built with the MASS package in the R 4.0.4 environment.

3. Results

3.1. Characteristics of the Respondents

Detailed characteristics of the population are presented in Table 1. A total of 14,844 university students in Poland with an average age of 21.82 ± 2.8 participated in the study. A total of 7735 (52.1%) surveys were collected in the period before the declaration of the COVID-19 pandemic. The majority were women, 11,985 (80.7%), and 5,352 humanities students (36.1%). Similar frequencies were observed both before and during the pandemic. The study included a group of 3425 medical students (23.1%), in which the most numerous group were students from the medical and medical-dental faculty, 1884 (57.2%). The study was conducted according to the Helsinki Declaration and was approved by the Bioethics Committee at the Wroclaw Medical University.

3.2. Sleep Disturbance

Detailed results of sleep disturbance are presented in Table 2. Polish students obtained a mean AIS score of 8.40 ± 4.35, and as many as 8041 (54.1%) students scored at least 8 points, showing insomnia [32]. A total of 3644 (24.5%) respondents said their sleep time was satisfactory, while 4120 (27.7%) had satisfactory sleep quality. Only 955 (6.4%) did not report daytime sleepiness. Specific single AIS measures for the entire study group and the COVID-19 pandemic are presented in Table S1.
For the ESS’s somnolence subscale, the mean score was 7.77 ± 4.19. Somnolence was diagnosed in 3872 (26.1%) students, of which 892 (6.1%) declared suffering from pathological somnolence. The most common predisposition of sleep is lying down and resting after lunch (91.1%). Nearly 5.8% of students admitted that there are situations when they could fall asleep while driving a car for a few minutes to stop in a traffic jam. The list of ESS items is presented in Table S2, which is part of the Supplementary Materials.
The analysis of sociodemographic variables indicated that women had significantly higher mean AIS and ESS scores. Moreover, higher AIS and ESS scores were observed among first-year students. Interestingly, medical students with the lowest AIS values had at the same time the highest ESS measure. There was a correlation between the stimulants and ESS measures of sleep. Higher ESS scores were associated with psychostimulants, cannabinoids, and hypnotics use. On the other hand, both psychostimulants and hypnotics affected the AIS measures for students having on average higher values in both scales. There was an inverse correlation for the effects of alcohol on sleep because individuals who consumed alcohol obtained lower results on average on both scales.
There was no significant difference in the AIS measures between the period before and during the pandemic, p = 0.061. The analysis of separate items showed a significant decrease in sleep qualities for both stages as sleep was rated as satisfactory by 30.09% of students before the pandemic as compared to a percentage of 25.20% after the declaration of the pandemic (p < 0.001). However, after the pandemic had started, the percentage of students with adequate sleep time increased (20.97% vs. 28.44%, p < 0.001). A detailed list is presented in Tables S1 and S2.
The analysis of separate items showed that the factors of the well-being of the next day (r = 0.702, p < 0.001) and the subjective assessment of sleep quality (r = 0.663, p < 0.001) impacted the final AIS score most.
Similarly, the higher ESS scores correlated with the probability of falling asleep while reading (r = 0.585, p < 0.001) and during rest after lunch (r = 0.579, p < 0.001).

3.3. Quality of Life Assessment

Detailed MANSA results are presented in Table 3. The study found that the mean QoL was 60.95 ± 11.25. Women assessed their QOL significantly lower than men (p = 0.043). Among the stimulants used, both alcohol and cannabinoids were associated with a higher QOL score, unlike with hypnotics and psychostimulants. The period of the COVID-19 pandemic significantly lowered the QoL among Polish students (p < 0.001). Moreover, people suffering from insomnia and daytime sleepiness showed a much lower subjective assessment of the quality of life (p < 0.001).
The analysis of separate MANSA scores showed that Polish students gave the highest ratings for their satisfaction with the sense of security and relationships with their roommates. Because of the ongoing pandemic, there was a significant decrease in the subjective assessment of mental health (OR 1.49, p < 0.001), as well as the general feeling of satisfaction with life (OR 1.3, p < 0.001). During the pandemic, Polish students gave higher ratings for satisfaction with the housing situation (OR 0.81, p < 0.001) and relations with roommates (OR 0.88, p < 0.001). A detailed list of the MANSA items and their relationship with the COVID-19 pandemic is presented in Table 4.

3.4. Correlations between Individual Scales

There were significant correlations between the AIS, ESS, and QoL measurements used in the study. It was shown that the increase in AIS values was positively associated with the mean ESS score (r = 0.223, t = 27.983, p < 0.001). However, there was an inverse correlation between the assessment of sleep and QOL, because higher AIS (r = −0.477, t = −66.204, p < 0.001) and ESS (r = −0.129, t = −15.923, p < 0.001) scores correlated with a lower subjective QOL assessment (MANSA).

3.5. The Pattern of Stimulants/Alcohol and Drug Use among Polish Students

The drug use related to stimulants is presented in Table 1. Detailed effects of sociodemographics and the pandemic on drug use are shown in Table 5. The most common stimulants were alcohol, consumed by 87.7% of respondents, but after the COVID-19 pandemic burst, alcohol use had decreased from 91.3% to 84%. Hypnotics were used by 13% of the respondents, and psychostimulants were used by 2.9% of the university/undergraduate student population. There was a significant influence of gender on the type of stimulants. Women used sedatives/sleeping pills more often, whereas men consumed alcohol, and used cannabinoids and psychostimulants more often. With alcohol consumption, we observed a distinct pattern that a higher year of study was associated with increased alcohol use. It was also shown that after the COVID-19 pandemic burst, the frequency of using hypnotics/sedatives by Polish students increased significantly (OR 0.76, p < 0.001). However, as the pandemic continued, alcohol consumption decreased (OR 1.35, p < 0.001).

4. Discussion

Sleep disorders are a significant health problem, not only among the elderly but now also among young adults. Therefore, the central aim of this study was to assess the prevalence of sleep disorders among university students, including their QoL and patterns of psychoactive substance use. In addition, the study determined how the COVID-19 pandemic affected students’ quality of life. The study proved a considerable health problem of Polish students because it showed that 54.1% of the population sample had symptoms of insomnia as indicated on the AIS scale [31]. To the best of the authors’ knowledge, this has been the first report on such a large group of Polish students, and it includes observations both before and during the COVID-19 pandemic, which makes the study strong and innovative.
The ESS results showed the occurrence of daytime sleepiness in 26.1% of students, of which as much as 6.1% should suspect pathological sleepiness. The present results are consistent with other reports indicating a significant increase in sleep problems among young adults. For instance, in a study conducted in Morocco, the prevalence of insomnia was found in 54% of the students’ population, and 9.4% of them suffered from daytime sleepiness. In another study on Hungarian students, 23% of the population had insomnia [38,39]. However, as previously observed by Ohayon [40], the prevalence of sleep disorders varies depending on the data collection period, population sample, and research methods. For example, a Polish study on the assessment of sleep disorders among 2413 young Poles indicated that 50.5% of them declared difficulties with sleep [41]. Another study by Kałduńska et al. [42] in 2019 based on standardized psychometric tools found sleep disorders in 28.3% of respondents, among whom there was a large number of students from universities in Krakow—19.7% [42,43]. However, in a Polish study on 1,649 students during the lockdown in Poland, insomnia was diagnosed in 42.03% of the population sample [44]. Interestingly, in a large population study by Kiejna et al. [2], the occurrence of sleep disorders among Poles over 15 years of age was estimated at 27.3%. As mentioned earlier, these discrepancies more likely depended on the different periods of data collection, various research methods, and the selection of the population sample.
In this study and many previous reports, it was observed that women much more often suffer from sleep disorders [2,6,39,41,45]. This report found that women scored higher in both AIS and ESS scales. These findings are not clear. Undoubtedly, women show a higher level of emotional excitability and therefore are more at risk of developing psychiatric diseases, including anxiety and depression, which are associated with sleep problems. It is believed that this results from sex steroid hormones whose levels are different between genders after puberty [46]. The concentration of hormones in women is related to the menstrual cycle, affecting assessments of the quality and duration of sleep [47,48]. Some studies have shown that high estradiol and progesterone levels were associated with prolonged arousal and wakefulness [49]. There was also a unidirectional growing intensification of both insomnia and daytime sleepiness in the first-year students, obtaining higher AIS and ESS scores. These effects may be explained by appearances of life changes associated with the university enrolment, including change of place of residence, new social roles, and new life obligations. These changes can induce anxiety and fear, correlated with the risk of developing sleep disorders, as confirmed in earlier reports [50,51].
Contrary to the previous observations, in this study, medical students showed significantly lower AIS scores than students from other studies. In ESS, these values were highest, and the percentage of people with a positive result was 30.24%. In a survey among medical university students, daytime sleepiness occurred in 35% of Malaysian students, 30.6% of Indian students, and 46.5% of Brazilian medical adepts [15,52,53]. It is believed that high sleepiness among medical students is associated with many hours of classes, study, clinical practice, often including night duty, and significant stress and mental strain [54].
The comparison of separate AIS items showed a moderate correlation between the result and the question about sleep quality (r = 0.663, p < 0.001). This effect seems to be consistent with the reports worldwide indicating that the quality, but not the time, of sleep is most important (r = 0.578, p < 0.001). This may also be the result of no AIS differences between periods before and during the COVID-19 pandemic. During the lockdown, universities were closed, and students switched to remote learning. Their scope of decreased duties could contribute to changing their sleep pattern. For instance, Gupta et al. [55] observed that students went to sleep late more often during the lockdown, got up later, and had a greater number of naps during the day, which reduced the quality of sleep.
Another explanation could be that students had longer sleep during the day because of life changes. Here, we observed that the percentage of students with normal sleep time increased from 20.97% to 28.44%, p < 0.001, while sleep satisfaction decreased from 30.09% to 25.20%, p < 0.001. It is clear that delayed falling asleep can reduce the amount of slow-wave sleep, significantly deteriorating its quality and exacerbating sleep problems [53,54]. Similar findings were also observed among Spanish students as there was an increase in sleep time in the initial period of the pandemic [25]. In contrast, in a study conducted in Jordan, 94.9% of students declared that the pandemic had affected their sleep habits, and 74% of them reported a subjective deterioration in sleep quality. Additionally, 71.3% of students showed symptoms of depression [22]. The COVID-19 pandemic is an unusual situation, having a considerable impact on people’s health and psychological condition. Recent reports have shown an increased risk of depression, anxiety, sleep disorders, and PTSD in almost every age group [23]. In addition, the present results of the subjective assessment of mental condition showed a decreasing tendency when comparing periods during and before the pandemic (OR 1.49, p < 0.001) and the QOL (OR 1.30, p < 0.001). Thus, the impact of the COVID-19 pandemic on mental health seems to be complex, demanding constant monitoring, especially given successive waves of the disease. We should note that, despite the social distancing, socialization was rated by Polish university students as being more satisfied with the housing situation (OR 0.81, p < 0.001) and relations with roommates (OR 0.88, p < 0.001).
Psychoactive substances influencing sleep include alcohol, cannabinoids, cocaine, or morphine [11,12,13,56,57]. The study confirmed the relationship between sleep and substance use. We showed that psychostimulants and sedatives-hypnotics were associated with AIS scores, while alcohol consumption was associated with lower AIS scores. However, the EPSS measurement showed that alcohol, cannabinoids, psychostimulants, and hypnotics affected daytime sleepiness. The finding of the effect of stimulants on sleep is not clear. For example, alcohol consumption in the initial stage may lead to a subjective improvement in sleep [58]. However, its only long-term use that can disturb sleep by extending its latency time, shortening the duration of sleep, and leading to frequent awakenings, thus significantly diminishing its quality [58,59]. The cannabinoids have a similar effect on sleep, but in the short-term manner, subjectively improving sleep quality [58]. In the study investigating the subjective evaluation of cannabis’ effect on sleep, the respondents indicated the ease of falling asleep as the main advantage of drug use [60]. Similar findings were confirmed in polysomnography studies of small THC doses, leading to shorter falling-asleep times, shorter sleep latencies, and shorter awakening times [61]. However, for chronic alcoholic use, even at low doses, there is a negative effect on sleep [62]. The most common subjective feelings are bizarre dreams, decreased sleep quality, and insomnia [63,64]. On the other hand, there is substantial evidence that substance use reduces the quality of sleep and adverse next-day effects on memory [65], as indicated in this study in a higher percentage of people with positive ESS and AIS scores. It is worth noting that the relationships between sleep and substance use seem to be bidirectional: the incidence of sleep disorders affects the increased risk of using psychoactive substances, and vice versa, their use leads to sleep deterioration. There is also evidence that the sleep disorders after discontinuation of psychostimulants may be an independent factor predisposed to relapse [62]. However, that requires in-depth analysis that goes beyond this study. The study showed that at the initial stage of the COVID-19 pandemic, there was a significant decrease in alcohol use among students in Poland. Similar findings were observed among students from the USA, Portugal, or Germany [66,67,68]. This effect was probably due to the prevailing restrictions, e.g., the closure of bars, restaurants, pubs, and universities, and the introduction of distance learning. This resulted in the deprivation of in-person social interactions often associated with alcohol consumption. This was also confirmed by the change in drinking habits, for instance, smaller amounts were consumed more often with the family [66,67,68]. The study among Spanish students showed a decline in alcohol and tobacco consumption as well as pro-health habits, such as increasing physical activity and consumption of fruit and vegetables. Some researchers hypothesized that the COVID-19 pandemic intensified some health-promoting habits due to the fear of the virus and death [25]. On the other hand, another study in the US assessing alcohol consumption before and after university closure showed an increased alcohol consumption and excessive searching for drinking opportunities among students [24]. Therefore, the patterns of substance use in the COVID-19 pandemic seem to vary given the study site, and its period and individual predispositions, consequently, it should be subjected to further monitoring. Interestingly, there was an inverse pattern in hypnotics/sedatives as their consumption increased during the COVID-19 pandemic. Undoubtedly, this effect may be explained by an increase in anxiety and depression, and sleep disorders [69]. Moreover, the period of the COVID-19 pandemic is also reflected in the assessment of our sleep. While the study results did not show any differences between the stages in the mean AIS values, these observations are visible in individual questions. The quality of sleep decreased significantly while its length increased.
The authors are aware of limitations of this study. The first limitation of the study was data collection. This resulted in difficulties in precise estimation of the number of participants who received the information and participants who replied. Additionally, it was not possible to determine the number of questionnaires that were initially finished and then not completed at each stage. Moreover, the anonymity of the study prevented the authors from providing information about the results and information about the potential need for specialist consultations. Another limitation was the limited representativeness of the Polish university students, such as most women, students of humanities, and first-year students. The measurements used also had some limitations. The self-reported scales were based on subjective feelings, but in-depth psychiatric research requires objectification, such as a psychiatric examination or standardized instruments. However, the scales used were comparable to the tools of, e.g., polysomnography, where satisfactory results were obtained [70,71]. The findings were also limited as no data on somatic diseases, medications, and mental disorders among the respondents and their family members were provided, as well as many other important sociodemographic factors. However, it should be emphasized that the study used reliable research methods and a large sample size. Limitations included the lack of measurements of the level of addiction to the substances used, as well as the assessment of day/night activity among respondents, which, according to the literature, have an impact on sleep quality [72].
To sum up, this study provides important findings on the epidemiology of sleep disorders, including somnolence and insomnia, and the subjective assessment of QOL among young adults studying in Poland. It indicated the specific psychoactive substance use patterns in Polish university students. It turned out that insomnia may be a common phenomenon as 54% of the surveyed students were prone to its symptoms. In addition, the study showed that the COVID-19 pandemic increased daytime sleepiness, worsening the quality of sleep without increasing the phenomenon of general insomnia. Compared to other reports, there was a significant increase in sleep problems among adults in Poland before the pandemic. However, the heterogeneity of the study groups, different periods of data collection, and different research methods prevented conclusive results from being obtained. Therefore, further research on sleep disorders requires an in-depth analysis based on a standardized methodology to objectify the final conclusions. Therefore, the authors have made an effort, and research is currently underway to disseminate the questionnaire in many countries around the world. The publication of the results is planned shortly.

5. Conclusions

Sleep disorders are a significant health problem for young adults living in Poland. The impact of the COVID-19 pandemic on sleep is not fully clear. As the pandemic has progressed, the quality of students’ sleep has decreased, and the phenomenon of daytime sleepiness may have also increased. There were no differences in severity of insomnia before and during the COVID-19 pandemic among Polish students. Ultimately, we found that substance use is widespread in young adults, affecting either sleep or their quality of life. Our findings also suggested the increased use of sedatives/hypnotics and decreased alcohol consumption during the COVID-19 pandemic.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jcm11082106/s1. Table S1. A detailed list of the individual questions included in the Athens Insomnia Scale, divided into the period before and during the COVID-19 pandemic. Table S2. A detailed list of questions included in the Epworth Sleepiness Scale, divided into the period before and during the COVID-19 pandemic.

Author Contributions

Conceptualization, M.B. and P.P., methodology, M.B. and P.P., software, M.B., validation, M.B., P.P. and A.M.-M., formal analysis, M.B. and P.P., investigation, M.B. and P.P., resources, M.B., data curation, M.B., writing—original draft preparation, M.B., writing—review and editing, P.P. and A.M.-M., visualization, M.B., P.P. and A.M.-M., supervision, P.P. and A.M.-M., project administration, A.M.-M., funding acquisition, A.M.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was carried out on the subject according to the records in the Simple system with the number SUBZ.C290.22.090 of the Wroclaw Medical University, Poland.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Bioethics Committee of the Wroclaw Medical University, Poland. (approval number: KB-234/2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We would like to express our appreciation to Krzysztof Kujawa from the Statistical Analysis Center at the Wroclaw Medical University for his support in statistical analyses.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sigurdson, K.; Ayas, N.T. The public health and safety consequences of sleep. Can. J. Physiol. Pharmacol. 2007, 85, 179–183. [Google Scholar] [CrossRef] [PubMed]
  2. Kiejna, A.; Wojtyniak, B.; Rymaszewska, J.; Stokwiszewski, J. Prevalence of insomnia in Poland—results of the National Health Interview Survey. Acta Neuropsychiatr. 2003, 15, 68–73. [Google Scholar] [CrossRef] [PubMed]
  3. Lemma, S.; Gelaye, B.; Berhane, Y.; Worku, A.; Williams, M.A. Sleep quality and its psychological correlates among university students in Ethiopia: A cross-sectional study. BMC Psychiatry 2012, 12, 237. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Byrd, K.L.; Gelaye, B.; Tadessea, M.G.; Williams, M.A.; Lemma, S.; Berhanec, Y. Sleep Disturbances and Common Mental Disorders in College Students. Health Behav. Policy Rev. 2014, 1, 229–237. [Google Scholar] [CrossRef] [PubMed]
  5. Sivertsen, B.; Vedaa, Ø.; Harvey, A.G.; Glozier, N.; Pallesen, S.; Aarø, L.E.; Lønning, K.J.; Hysing, M. Sleep patterns and insomnia in young adults: A national survey of Norwegian university students. J. Sleep Res. 2019, 28, e12790. [Google Scholar] [CrossRef] [PubMed]
  6. Piotrowski, P.; Babicki, M.; Maślanka, P.; Kotowicz, K.; Marciniak, D.; Rymaszewska, J. Assessment of sleep disorders and use of psychoactive drugs among Polish students. Psychiatr. Pol. 2020, 54, 1007–1024. [Google Scholar] [CrossRef]
  7. Brick, C.A.; Seely, D.L.; Palermo, T.M. Association Between Sleep Hygiene and Sleep Quality in Medical Students. Behav. Sleep Med. 2010, 8, 113–121. [Google Scholar] [CrossRef] [Green Version]
  8. Preišegolavičiūtė, E.; Leskauskas, D.; Adomaitienė, V. Associations of quality of sleep with lifestyle factors and profile of studies among Lithuanian students. Medicina 2010, 46, 482. [Google Scholar] [CrossRef] [Green Version]
  9. Carskadon, M.A.; Acebo, C.; Jenni, O.G. Regulation of Adolescent Sleep: Implications for Behavior. Ann. N. Y. Acad. Sci. 2004, 1021, 276–291. [Google Scholar] [CrossRef]
  10. Gaultney, J.F. The Prevalence of Sleep Disorders in College Students: Impact on Academic Performance. J. Am. Coll. Health 2010, 59, 91–97. [Google Scholar] [CrossRef] [Green Version]
  11. Hamilton, K.; Ng, H.T.H.; Zhang, C.-Q.; Phipps, D.J.; Zhang, R. Social Psychological Predictors of Sleep Hygiene Behaviors in Australian and Hong Kong University Students. Int. J. Behav. Med. 2021, 28, 214–226. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Batisse, A.; Leger, S.; Vicaut, E.; Gerbaud, L.; Djezzar, S. COgnitive enhancement and consumption of psychoactive Substances among Youth Students (COSYS): A cross-sectional study in France. Public Health 2021, 194, 75–78. [Google Scholar] [CrossRef] [PubMed]
  13. Aguocha, C.M.; Nwefoh, E. Prevalence and correlates of substance use among undergraduates in a developing country. Afr. Health Sci. 2021, 21, 875–883. [Google Scholar] [CrossRef] [PubMed]
  14. Ratcliff, R.; Van Dongen, H.P.A. Sleep deprivation affects multiple distinct cognitive processes. Psychon. Bull. Rev. 2009, 16, 742–751. [Google Scholar] [CrossRef] [Green Version]
  15. Giri, P.; Baviskar, M.; Phalke, D. Study of Sleep Habits and Sleep Problems Among Medical Students of Pravara Institute of Medical Sciences Loni, Western Maharashtra, India. Ann. Med Health Sci. Res. 2013, 3, 51–54. [Google Scholar] [CrossRef] [Green Version]
  16. Wolfson, A.R.; Carskadon, M.A. Understanding adolescent’s sleep patterns and school performance: A critical appraisal. Sleep Med. Rev. 2003, 7, 491–506. [Google Scholar] [CrossRef]
  17. Haile, Y.G.; Alemu, S.M.; Habtewold, T.D. Insomnia and Its Temporal Association with Academic Performance among University Students: A Cross-Sectional Study. BioMed Res. Int. 2017, 2017, 2542367. [Google Scholar] [CrossRef]
  18. Stickgold, R. Sleep-dependent memory consolidation. Nature 2005, 437, 1272–1278. [Google Scholar] [CrossRef]
  19. Ahrberg, K.; Dresler, M.; Niedermaier, S.; Steiger, A.; Genzel, L. The interaction between sleep quality and academic performance. J. Psychiatr. Res. 2012, 46, 1618–1622. [Google Scholar] [CrossRef]
  20. Oh, Y.H.; Kim, H.; Kong, M.; Oh, B.; Moon, J.H. Association between weekend catch-up sleep and health-related quality of life of Korean adults. Medicine 2019, 98, e14966. [Google Scholar] [CrossRef]
  21. Itani, O.; Jike, M.; Watanabe, N.; Kaneita, Y. Short sleep duration and health outcomes: A systematic review, meta-analysis, and meta-regression. Sleep Med. 2017, 32, 246–256. [Google Scholar] [CrossRef]
  22. Saadeh, H.; Saadeh, M.; Almobaideen, W.; Al Refaei, A.; Shewaikani, N.; Al Fayez, R.Q.; Khawaldah, H.; Abu-Shanab, S.; Al-Hussaini, M. Effect of COVID-19 Quarantine on the Sleep Quality and the Depressive Symptom Levels of University Students in Jordan During the Spring of 2020. Front. Psychiatry 2021, 12, 605676. [Google Scholar] [CrossRef] [PubMed]
  23. Xiong, J.; Lipsitz, O.; Nasri, F.; Lui, L.M.W.; Gill, H.; Phan, L.; Chen-Li, D.; Iacobucci, M.; Ho, R.; Majeed, A.; et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J. Affect. Disord. 2020, 277, 55–64. [Google Scholar] [CrossRef] [PubMed]
  24. Lechner, W.V.; Laurene, K.R.; Patel, S.; Anderson, M.; Grega, C.; Kenne, D.R. Changes in alcohol use as a function of psychological distress and social support following COVID-19 related University closings. Addict. Behav. 2020, 110, 106527. [Google Scholar] [CrossRef] [PubMed]
  25. López-Bueno, R.; Calatayud, J.; Casaña, J.; Casajús, J.A.; Smith, L.; Tully, M.A.; Andersen, L.L.; López-Sánchez, G.F. COVID-19 Confinement and Health Risk Behaviors in Spain. Front. Psychol. 2020, 11, 1426. [Google Scholar] [CrossRef]
  26. WHOQOL. The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Soc. Sci. Med. 1995, 41, 1403–1409. [Google Scholar] [CrossRef]
  27. World Health Organization. Division of Mental Health and Prevention of Substance Abuse WHOQOL: Measuring Quality of Life; World Health Organization: Geneva, Switzerland, 1997. [Google Scholar]
  28. Kulikowski, K. Quality of life in the context of psychology and medicine. Reumatologia/Rheumatology 2014, 52, 200–206. [Google Scholar] [CrossRef]
  29. Mościcka, S.; Wójcik, D.L.; Mamcarz, A. Quality of life in patients with ischaemic heart disease. Chor. Serca Naczyń 2015, 12, 282–288. [Google Scholar]
  30. Soldatos, C.R.; Dikeos, D.G.; Paparrigopoulos, T.J. Athens Insomnia Scale: Validation of an instrument based on ICD-10 criteria. J. Psychosom. Res. 2000, 48, 555–560. [Google Scholar] [CrossRef]
  31. Fornal-Pawłowska, M.; Wołyńczyk-Gmaj, D.; Szelenberger, W. Validation of the Polish version of the Athens Insomnia Scale. Psychiatr. Pol. 2011, 45, 211–221. [Google Scholar]
  32. Soldatos, C.R.; Dikeos, D.G.; Paparrigopoulos, T.J. The diagnostic validity of the Athens Insomnia Scale. J. Psychosom. Res. 2003, 55, 263–267. [Google Scholar] [CrossRef]
  33. Hurlston, A.; Foster, S.N.; Creamer, J.; Brock, M.S.; Matsangas, P.; Moore, B.A.; Mysliwiec, V. The Epworth Sleepiness Scale in Service Members with Sleep Disorders. Mil. Med. 2019, 184, e701–e707. [Google Scholar] [CrossRef] [PubMed]
  34. Johns, M.W. A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep 1991, 14, 540–545. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Lapin, B.R.; Bena, J.F.; Walia, H.K.; Moul, D.E. The Epworth Sleepiness Scale: Validation of One-Dimensional Factor Structure in a Large Clinical Sample. J. Clin. Sleep Med. 2018, 14, 1293–1301. [Google Scholar] [CrossRef] [Green Version]
  36. Oliver, J.P.J.; Huxley, P.J.; Priebe, S.; Kaiser, W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc. Psychiatry Psychiatr. Epidemiol. 1997, 32, 76–83. [Google Scholar] [CrossRef] [PubMed]
  37. Priebe, S.; Huxley, P.; Knight, S.; Evans, S. Application and Results of the Manchester Short Assessment of Quality of Life. Int. J. Soc. Psychiatry 1999, 45, 7–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Zavecz, Z.; Nagy, T.; Galkó, A.; Nemeth, D.; Janacsek, K. The relationship between subjective sleep quality and cognitive performance in healthy young adults: Evidence from three empirical studies. Sci. Rep. 2020, 10, 4855. [Google Scholar] [CrossRef] [Green Version]
  39. Idrissi, A.J.; Lamkaddem, A.; Benouajjit, A.; Ben El Bouaazzaoui, M.; El Houari, F.; Alami, M.; Labyad, S.; Chahidi, A.; Benjelloun, M.; Rabhi, S.; et al. Sleep quality and mental health in the context of COVID-19 pandemic and lockdown in Morocco. Sleep Med. 2020, 74, 248–253. [Google Scholar] [CrossRef]
  40. Ohayon, M.M. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med. Rev. 2002, 6, 97–111. [Google Scholar] [CrossRef]
  41. Nowicki, Z.; Grabowski, K.; Cubała, W.; Nowicka-Sauer, K.; Zdrojewski, T.; Rutkowski, M.; Bandosz, P. Prevalence of self-reported insomnia in general population of Poland. Psychiatr. Pol. 2016, 50, 165–173. [Google Scholar] [CrossRef]
  42. Kałduńska, J.; Skonieczna-Żydecka, K.; Ryterska, K.; Palma, J.; Żwierełło, W.; Maciejewska-Markiewicz, D.; Czerwińska-Rogowska, M.; Wolska, A.; Stachowska, Z.; Budawski, R.; et al. Depressive Disorders and Sleeping Disturbances—Surveys Study of 923 Participants on the Pol’and’Rock Festival, Kostrzyn, Poland 2019. Int. J. Environ. Res. Public Health 2020, 17, 8092. [Google Scholar] [CrossRef] [PubMed]
  43. Średniawa, A.; Drwiła, D.; Krotos, A.; Wojtaś, D.; Kostecka, N.; Tomasik, T. Insomnia and the level of stress among students in Krakow, Poland. Trends Psychiatry Psychother. 2019, 41, 60–68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Gruba, G.; Kasiak, P.S.; Gębarowska, J.; Adamczyk, N.; Sikora, Z.; Jodczyk, A.M.; Mamcarz, A.; Śliż, D. PaLS Study of Sleep Deprivation and Mental Health Consequences of the COVID-19 Pandemic among University Students: A Cross-Sectional Survey. Int. J. Environ. Res. Public Health 2021, 18, 9581. [Google Scholar] [CrossRef] [PubMed]
  45. Marelli, S.; Castelnuovo, A.; Somma, A.; Castronovo, V.; Mombelli, S.; Bottoni, D.; Leitner, C.; Fossati, A.; Ferini-Strambi, L. Impact of COVID-19 lockdown on sleep quality in university students and administration staff. J. Neurol. 2021, 268, 8–15. [Google Scholar] [CrossRef]
  46. Naninck, E.F.G.; Lucassen, P.J.; Bakker, J. Sex Differences in Adolescent Depression: Do Sex Hormones Determine Vulnerability? J. Neuroendocrinol. 2011, 23, 383–392. [Google Scholar] [CrossRef]
  47. Theorell-Haglöw, J.; Miller, C.B.; Bartlett, D.J.; Yee, B.J.; Openshaw, H.D.; Grunstein, R.R. Gender differences in obstructive sleep apnoea, insomnia and restless legs syndrome in adults—What do we know? A clinical update. Sleep Med. Rev. 2018, 38, 28–38. [Google Scholar] [CrossRef]
  48. Krishnan, V.; Collop, N.A. Gender differences in sleep disorders. Curr. Opin. Pulm. Med. 2006, 12, 383–389. [Google Scholar] [CrossRef]
  49. Kagan, R.; Constantine, G.; Kaunitz, A.M.; Bernick, B.; Mirkin, S. Improvement in sleep outcomes with a 17β-estradiol–progesterone oral capsule (TX-001HR) for postmenopausal women. Menopause 2018, 26, 622–628. [Google Scholar] [CrossRef]
  50. Li, Y.; Bai, W.; Zhu, B.; Duan, R.; Yu, X.; Xu, W.; Wang, M.; Hua, W.; Yu, W.; Li, W.; et al. Prevalence and correlates of poor sleep quality among college students: A cross-sectional survey. Health Qual. Life Outcomes 2020, 18, 210. [Google Scholar] [CrossRef]
  51. Cheng, S.H.; Shih, C.-C.; Lee, I.H.; Hou, Y.-W.; Chen, K.C.; Chen, K.-T.; Yang, Y.K.; Yang, Y.-C. A study on the sleep quality of incoming university students. Psychiatry Res. 2012, 197, 270–274. [Google Scholar] [CrossRef]
  52. Zailinawati, A.-H.; Mazza, D.; Teng, C.L. Prevalence of insomnia and its impact on daily function amongst Malaysian primary care patients. Asia Pac. Fam. Med. 2012, 11, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Perotta, B.; Arantes-Costa, F.M.; Enns, S.C.; Figueiro-Filho, E.A.; Paro, H.; Santos, I.S.; Lorenzi-Filho, G.; Martins, M.A.; Tempski, P.Z. Sleepiness, sleep deprivation, quality of life, mental symptoms and perception of academic environment in medical students. BMC Med Educ. 2021, 21, 111. [Google Scholar] [CrossRef] [PubMed]
  54. Wong, J.G.W.S.; Patil, N.G.; Beh, S.L.; Cheung, E.P.T.; Wong, V.; Chan, L.C.; Lieh Mak, F.L. Cultivating psychological well-being in Hong Kong’s future doctors. Med Teach. 2005, 27, 715–719. [Google Scholar] [CrossRef] [PubMed]
  55. Gupta, R.; Grover, S.; Basu, A.; Krishnan, V.; Tripathi, A.; Subramanyam, A.; Nischal, A.; Hussain, A.; Mehra, A.; Ambekar, A.; et al. Changes in sleep pattern and sleep quality during COVID-19 lockdown. Indian J. Psychiatry 2020, 62, 370–378. [Google Scholar] [CrossRef] [PubMed]
  56. Valerio, T.D.; Kim, M.J.; Sexton-Radek, K. Association of Stress, General Health, and Alcohol Use with Poor Sleep Quality among U.S. College Students. Am. J. Health Educ. 2016, 47, 17–23. [Google Scholar] [CrossRef]
  57. Borbély, A.A.; Daan, S.; Wirz-Justice, A.; DeBoer, T. The two-process model of sleep regulation: A reappraisal. J. Sleep Res. 2016, 25, 131–143. [Google Scholar] [CrossRef]
  58. Conroy, D.A.; Arnedt, J.T. Sleep and Substance Use Disorders: An Update. Curr. Psychiatry Rep. 2014, 16, 487. [Google Scholar] [CrossRef]
  59. Brower, K.J. Insomnia, alcoholism and relapse. Sleep Med. Rev. 2003, 7, 523–539. [Google Scholar] [CrossRef]
  60. Vitiello, M.V. Sleep, alcohol and alcohol abuse. Addict. Biol. 1997, 2, 151–158. [Google Scholar] [CrossRef]
  61. Kaul, M.; Zee, P.C.; Sahni, A.S. Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders. Neurotherapeutics 2021, 18, 217–227. [Google Scholar] [CrossRef]
  62. Angarita, G.A.; Emadi, N.; Hodges, S.; Morgan, P.T. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: A comprehensive review. Addict. Sci. Clin. Pract. 2016, 11, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Budney, A.J.; Moore, B.A.; Vandrey, R.G.; Hughes, J.R. The time course and significance of cannabis withdrawal. J. Abnorm. Psychol. 2003, 112, 393–402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Budney, A.J.; Hughes, J.R.; Moore, B.A.; Novy, P.L. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch. Gen. Psychiatry 2001, 58, 917–924. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Whitehurst, L.N.; Mednick, S.C. Psychostimulants may block long-term memory formation via degraded sleep in healthy adults. Neurobiol. Learn. Mem. 2021, 178, 107342. [Google Scholar] [CrossRef] [PubMed]
  66. Graupensperger, S.; Jaffe, A.E.; Fleming, C.N.B.; Kilmer, J.R.; Lee, C.M.; Larimer, M.E. Changes in College Student Alcohol Use During the COVID-19 Pandemic: Are Perceived Drinking Norms Still Relevant? Emerg. Adulthood 2021, 9, 531–540. [Google Scholar] [CrossRef]
  67. Vasconcelos, M.; Crego, A.; Rodrigues, R.; Almeida-Antunes, N.; López-Caneda, E. Effects of the COVID-19 Mitigation Measures on Alcohol Consumption and Binge Drinking in College Students: A Longitudinal Survey. Int. J. Environ. Res. Public Health 2021, 18, 9822. [Google Scholar] [CrossRef]
  68. Steffen, J.; Schlichtiger, J.; Huber, B.C.; Brunner, S. Altered alcohol consumption during COVID-19 pandemic lockdown. Nutr. J. 2021, 20, 44. [Google Scholar] [CrossRef]
  69. Babicki, M.; Bogudzińska, B.; Kowalski, K.; Mastalerz-Migas, A. Anxiety and Depressive Disorders and Quality of Life Assessment of Poles—A Study Covering Two Waves of the COVID-19 Pandemic. Front. Psychiatry 2021, 12, 704248. [Google Scholar] [CrossRef]
  70. Kasperczyk, J.; Jośko, J. Evaluation of the prevalence and determinants of shift work sleep disorders. Med. Pr. 2012, 63, 573–583. [Google Scholar]
  71. Sanford, S.D.; Lichstein, K.L.; Durrence, H.H.; Riedel, B.W.; Taylor, D.J.; Bush, A.J. The influence of age, gender, ethnicity, and insomnia on Epworth sleepiness scores: A normative US population. Sleep Med. 2006, 7, 319–326. [Google Scholar] [CrossRef]
  72. Plescia, F.; Cirrincione, L.; Martorana, D.; Ledda, C.; Rapisarda, V.; Castelli, V.; Martines, F.; Vinnikov, D.; Cannizzaro, E. Alcohol Abuse and Insomnia Disorder: Focus on a Group of Night and Day Workers. Int. J. Environ. Res. Public Health 2021, 18, 13196. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. Characteristics of the study group.
Table 1. Characteristics of the study group.
VariableOverall Study Group N (%)Before Pandemic N (%)During Pandemic N (%)Chi2p
SexFemale11,985 (80.7)6129 (79.2)5859 (82.4)25.38<0.001
Male2859 (19.3)1612 (20.8)1248 (17.6)
Age M ± SD21.82 ± 2.8 21.97 ± 2.4221.71 ± 4.74-<0.001
Study yearI4842 (32.7)1866 (24.1)2977 (41.9)573.05<0.001
II2767 (18.6)1717 (22.2)1050 (14.8)
III2781 (18.7)1690 (21.8)1093 (15.4)
IV2080 (14.0)1131 (14.6)949 (13.4)
V1984 (13.4)1129 (14.6)855 (12.0)
VI390 (2.6)208 (2.7)183 (2.6)
University profileMedical3425 (23.1)2082 (26.9)1344 (18.9)133.09<0.001
Non-Medical11,419 (76.9)5659 (73.1)5763 (81.1)
Study courseMedical3425 (23.1)2082 (26.9)1344 (18.9)159.41<0.001
Technical2676 (18.0)1348 (17.5)1329 (18.7)
Humanistic5352 (36.1)2524 (32.6)2829 (39.8)
Biological915 (6.1)480 (6.2)436 (6.1)
Economic2472 (16.7)1303 (16.8)1169 (16.5)
Faculty in the medical courseMedical/Dental1884 (57.2)1119 (56.0)765 (58.9)31.57<0.001
Pharmacy354 (10.7)263 (13.2)91 (7.0)
Faculty of Health Sciences1058 (32.1)616 (30.8)443 (34.1)
COVID-19 pandemic status announcementBefore pandemic7735 (52.1)----
During pandemic7105 (47.9)--
Use of stimulants in the last 3 months
AlcoholYes13,039 (87.8)7069 (91.3)5973 (84.0)183.55<0.001
No1805 (12.2)672 (8.7)1134 (16.0)
CannabinoidsYes1978 (13.3)1082 (14)898 (12.6)5.770.016
No12,866 (86.7)6659 (86.0)6209 (87.4)
PsychostimulantsYes417 (2.9)218 (2.8)200 (2.8)0.0050.993
No14,427 (97.1)7532 (97.2)6907 (97.2)
SedativesYes1933 (13.0)904 (11.7)1029 (14.5)25.66<0.001
No12,911 (87.0)6837 (88.3)6078 (85.5)
Table
Table 2. Linear regression model of the influence of sociodemographics and stimulants on AIS and ESS scales.
Table 2. Linear regression model of the influence of sociodemographics and stimulants on AIS and ESS scales.
Explanatory VariablePercentage of Positive ResultsB95%Cltp
Athens Insomnia Scale
COVID-19 pandemic status announcementBefore pandemic54.83%−0.085[−0.174, 0.003]−1.8790.061
During pandemic54.51%Ref.Ref.Ref.Ref.
SexFemale55.90%0.467[0.378, 0.557]10.283<0.001
Male44.10%Ref.Ref.Ref.Ref.
Study yearI55.48%0.151[0.004, 0.009]2.1000.035
II56.02%0.182[0.003, 0.015]2.1430.015
III53.90%−0.042[−0.208, 0.122]−0.5080.611
IV52.50%−0.225[−0.405, −0.043]−2.4340.014
V50.25%−0.259[−0.444, −0.075]−2.7590.005
VI54.99%Ref.Ref.Ref.Ref.
Study courseMedical50.88%−0.404[−0.546, −0.263]−5.586<0.001
Technical52.90%−0.194[−0.345, −0.041]−2.4990.012
Humanistic57.91%0.378[0.253, 0.498]6.022<0.001
Biological60.15%0.601[0.358, 0.834]5.052<0.001
Economic49.80%Ref.Ref.Ref.Ref.
Faculty in the medical courseMedical/Dental48.99%−0.282[−0.512, −0.052]−2.4010.016
Pharmacy47.74%−0.137[−0.491, 0.217]−0.7590.447
Faculty of Health Sciences54.86%Ref.Ref.Ref.Ref.
AlcoholYes53.94%−0.204[−0.315, −0.094]−3.63<0.001
No55.70%Ref.Ref.Ref.Ref.
CannabinoidsYes53.48%Ref.Ref.Ref.Ref.
No54.26%−0.031[−0.134, 0.072]−0.5910.553
PsychostimulantsYes58.85%Ref.Ref.Ref.Ref.
No54.02%−0.356[−0.568, −0.144]−3.291<0.001
SedativesYes78.43%Ref.Ref.Ref.Ref.
No50.52%−1.700[−1.800, −1.599]−33.115<0.001
Epworth Sleepiness Scale
COVID-19 pandemic status announcementBefore pandemic28.33%0.326[0.241, 0.412]7.493<0.001
During pandemic23.62%Ref.Ref.Ref.Ref.
SexFemale27.48%0.477[0.390, 0.562]10.915<0.001
Male20.21%Ref.Ref.Ref.Ref.
Study yearI26.68%0.201[0.066, 0.336]2.9230.003
II27.25%0.223[0.063, 0.383]2.7320.006
III26.70%0.055[−0.103, 0.215]0.6850.049
IV23.89%−0.151[−0.324, 0.022]−1.7010.088
V24.19%−0.167[−0.344, 0.010]−1.8470.065
VI27.11%Ref.Ref.Ref.Ref.
Study courseMedical30.24%0.409[0.272, 0.545]5.867<0.001
Technical24.80%−0.086[−0.232, 0.060]−1.1540.249
Humanistic25.11%−0.033[−0.151, 0.085]−0.55140.581
Biological27.18%−0.044[−0.268, 0.180]−0.3840.701
Economic23.42%Ref.Ref.Ref.Ref.
Faculty in the medical courseMedical/Dental28.82%−0.268[−0.500, −0.035]−2.2610.023
Pharmacy31.92%0.081[−0.2767, 0.439]0.4460.655
Faculty of Health Sciences32.20%Ref.Ref.Ref.Ref.
AlcoholYes26.32%0.196[0.090, 0.302]3.626<0.001
No24.31%Ref.Ref.Ref.Ref.
CannabinoidsYes28.89%Ref.Ref.Ref.Ref.
No25.65%−0.147[0.048, 0.247]−2.9160.003
PsychostimulantsYes32.30%Ref.Ref.Ref.Ref.
No25.90%−0.242[−0.455, −0.048]−2.4270.015
SedativesYes30.26%Ref.Ref.Ref.Ref.
No25.45%−0.143[−0.243, −0.043]−2.809<0.001
Notes: Statistically significant values are in bold with the significance level set at p < 0.05. Abbreviations: B—coefficient value of a given variable, 95% CI—confidence interval of B coefficient, t—test value, p—statistical significance. M—mean, SD—standard deviation.
Table
Table 3. Influence of sociodemographic variables, pandemic, stage of studies, insomnia, and daytime sleepiness on subjective QOL assessment in a linear regression model.
Table 3. Influence of sociodemographic variables, pandemic, stage of studies, insomnia, and daytime sleepiness on subjective QOL assessment in a linear regression model.
Explanatory VariableB95%CItp
MANSA Scale
COVID-19 pandemic status announcementBefore pandemic0.430[0.199, –0.661]3.653<0.001
During pandemicRef.Ref.Ref.Ref.
SexFemale−0.237[−0.468, −0.006]−2.0150.043
MaleRef.Ref.Ref.Ref.
Study yearI−0.866[−1.223, −0.504]−4.682<0.001
II−0.545[−0.975, −0.115]−2.4890.001
III−0.644[−1.072, −0.216]−2.9530.003
IV0.385[−0.08, 0.851]1.6160.105
V0.704[0.227, 1.181]2.8960.003
VIRef.Ref.Ref.Ref.
Study courseMedical2.238[1.873, 2.602]12.024<0.001
Technical0.049[−0.341, 0.439]0.2480.804
Humanistic−1.503[−1.817, −1.188]−9.360<0.001
Biological−0.891[−1.491, −0.291]−2.9120.003
EconomicRef.Ref.Ref.Ref.
Faculty in the medical courseMedical/Dental1.401[0.821, 1.982]4.731<0.001
Pharmacy−0.326[−1.221, 0.569]−0.7130.476
Faculty of Health SciencesRef.Ref.Ref.Ref.
Insomnia (AIS)Yes−8.923[−9.255, −8.589]−52.465<0.001
NoRef.Ref.Ref.Ref.
Daytime sleepiness (ESS)Yes−3.297[−3.706, −2.888]−15.801<0.001
NoRef.Ref.Ref.Ref.
AlcoholYes0.552[0.267, 0.834]3.793<0.001
NoRef.Ref.Ref.Ref.
CannabinoidsYesRef.Ref.Ref.Ref.
No−0.587[−.0853, −0.320]−4.301<0.001
PsychostimulantsYesRef.Ref.Ref.Ref.
No2.056[1.501, 2.603]7.372<0.001
SedativesYesRef.Ref.Ref.Ref.
No3.198[2.934, 3.465]23.719<0.001
Notes: Statistically significant values are in bold with the significance level set at p < 0.05. Abbreviations: B—coefficient value of a given variable, 95%CI—confidence interval of B coefficient, t—test value, p—statistical significance.
Table
Table 4. Polynomial logistic regression analysis of the relationship between separate MANSA subscales and the COVID-19 pandemic in the ordinance.
Table 4. Polynomial logistic regression analysis of the relationship between separate MANSA subscales and the COVID-19 pandemic in the ordinance.
QuestionMean Score for Both Phases of the StudyBefore the Pandemic Announcement
M
(SD)		OR
(95%CI)		p
How satisfied are you with your life as a whole today?4.592
(1.34)		1.30
(1.22–1.38)		<0.001
How satisfied are you with your job (or sheltered employment, or training/education as your main occupation)?4.441
(1.34)		0.915
(0.86–0.97)		<0.001
How satisfied are you with your financial situation?4.106
(1.53)		1.11
(1.04–1.18)		0.001
How satisfied are you with the number and quality of your friendships?4.667
(1.72)		1.09
(1.02–1.16)		0.006
How satisfied are you with your leisure activities (hobby)?4.223
(1.66)		1.04
(0.97–1.11)		0.201
How satisfied are you with your accommodation?4.764
(1.60)		0.81
(0.77–0.87)		<0.001
How satisfied are you with your personal safety?5.165
(1.42)		1.12
(1.06–1.20)		<0.001
How satisfied are you with the people that you live with?5.049
(1.55)		0.88
(0.83–0.94)		<0.001
How satisfied are you with your sexual life?4.268
(1.93)		1.09
(1.03–1.17)		0.002
How satisfied are you with your relationship with your family?4.962
(1.44)		1.14
(1.07–1.22)		<0.001
How satisfied are you with your physical health?4.301
(1.48)		1.04
(0.98–1.10)		0.216
How satisfied are you with your mental health?4.128
(1.68)		1.49
(1.40–1.58)		<0.001
Notes: Statistically significant values are in bold with the significance level set at p < 0.05. OR—odds ratio.
Table
Table 5. Polynomial logistic regression analysis of sociodemographics and pandemic effects on the frequency of stimulants/alcohol and drug use.
Table 5. Polynomial logistic regression analysis of sociodemographics and pandemic effects on the frequency of stimulants/alcohol and drug use.
VariablesAlcoholCannabinoidsPsychostimulantsSedatives
OR
(Cl 95%)		pOR
(Cl 95%)		pOR
(Cl 95%)		pOR
(Cl 95%)		p
Sex
(Female—Ref.)		Male1.45
(1.30–1.63)		<0.0012.10
(1.79–2.46)		<0.0012.10
(1.55–2.87)		<0.0010.66
(0.54–0.81)		<0.001
Study year
(I year—Ref.)		II0.83
(0.73–0.94)		0.0020.85
(0.68–1.05)		0.1470.81
(0.52–1.27)		0.3621.04
(0.85–1.27)		0.674
III1.02
(0.90–1.16)		0.7011.04
(0.85–1.26)		0.7330.99
(0.66–1.49)		0.9761.02
(0.84–1.24)		0.811
IV1.05
(0.92–1.21)		0.4010.87
(0.70–1.09)		0.238093
(0.60–1.45)		0.7600.83
(0.67–1.03)		0.096
V1.13
(0.99–1.30)		0.0710.69
(0.54–0.89)		<0.0010.61
(0.36–1.04)		0.7200.84
(0.67–1.06)		0.139
VI1.36
(1.04–1.80)		0.0270.61
(0.36–1.03)		0.0500.90
(0.36–2.25)		0.8261.04
(0.68–1.58)		0.855
Study course
(Biological—Ref.)		Economic1.00
(0.82–1.22)		0.9810.88
(0.61–1.28)		0.1560.79
(0.39–1.59)		0.5271.01
(0.73–1.40)		0.913
Humanistic0.83
(0.69–1.00)		0.0500.79
(0.58–1.09)		0.1481.06
(0.58–1.97)		0.8351.40
(1.04–1.87)		0.029
Medical0.88
(0.73–1.08)		0.2260.74
(0.54–1.01)		0.0590.94
(0.48–1.83)		0.8610.94
(0.68–1.29)		0.710
Technical1.18
(0.97–1.45)		0.0850.96
(0.70–1.30)		0.7991.12
(0.58–2.15)		0.7320.64
(0.46–0.88)		<0.001
Faculty in the medical course
(Pharmaceutical—Ref.)		Medical and dental1.57
(1.06–2.32)		0.0251.65
(0.78–3.52)		0.1873.05
(0.41–22.79)		0.2760.78
(0.43–1.43)		0.430
Health sciences1.44
(0.96–2.17)		0.0740.85
(0.38–1.90)		0.7001.24
(0.14–10.47)		0.8390.788
(0.42–1.49)		0.463
COVID-19 pandemic status announcement
(During pandemic—Ref.)		Before pandemic1.35
(1.27–1.44)		<0.0011.10
(0.98–1.23)		0.0830.93
(0.73–1.18)		0.5710.76
(0.69–0.85)		<0.001
Notes: Statistically significant values are in bold with the significance level set at p < 0.05.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Babicki, M.; Piotrowski, P.; Mastalerz-Migas, A. Assessment of Insomnia Symptoms, Quality of Life, Daytime Sleepiness, and Psychoactive Substance Use among Polish Students: A Cross-Sectional Online Survey for Years 2016–2021 before and during COVID-19 Pandemic. J. Clin. Med. 2022, 11, 2106. https://doi.org/10.3390/jcm11082106

AMA Style

Babicki M, Piotrowski P, Mastalerz-Migas A. Assessment of Insomnia Symptoms, Quality of Life, Daytime Sleepiness, and Psychoactive Substance Use among Polish Students: A Cross-Sectional Online Survey for Years 2016–2021 before and during COVID-19 Pandemic. Journal of Clinical Medicine. 2022; 11(8):2106. https://doi.org/10.3390/jcm11082106

Chicago/Turabian Style

Babicki, Mateusz, Patryk Piotrowski, and Agnieszka Mastalerz-Migas. 2022. "Assessment of Insomnia Symptoms, Quality of Life, Daytime Sleepiness, and Psychoactive Substance Use among Polish Students: A Cross-Sectional Online Survey for Years 2016–2021 before and during COVID-19 Pandemic" Journal of Clinical Medicine 11, no. 8: 2106. https://doi.org/10.3390/jcm11082106

APA Style

Babicki, M., Piotrowski, P., & Mastalerz-Migas, A. (2022). Assessment of Insomnia Symptoms, Quality of Life, Daytime Sleepiness, and Psychoactive Substance Use among Polish Students: A Cross-Sectional Online Survey for Years 2016–2021 before and during COVID-19 Pandemic. Journal of Clinical Medicine, 11(8), 2106. https://doi.org/10.3390/jcm11082106

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop